Navigation Links
Hot Topic Sessions to Highlight DIA's 21st Annual Euromeeting
Date:2/18/2009

The Drug Information Association's (DIA's) 21st Annual EuroMeeting will feature more than 125 sessions in 16 themes and 21 preconference tutorials focusing on issues affecting global drug discovery and development.

Basel, Switzerland (Vocus) February 18, 2009 -- The Drug Information Association's (DIA's) 21st Annual EuroMeeting will feature more than 125 sessions in 16 themes and 21 preconference tutorials focusing on issues affecting global drug discovery and development, including hot topics sessions on:

  • Regulatory Pharmacovigilance
  • Telematics
  • The Pharmaceutical Package
  • Advanced Therapies
  • New EMEA Transparency Policy
  • Pharmaceutical Sector Inquiry
  • EU Agreement: Administrative Regulatory Simplification
  • Adaptive Designs
  • Multinational Clinical Trials
  • Patient Recruitment
  • Personalised Medicine
  • Quality-by-Design
  • Medical Devices/Drug Combination Products
  • Biosimilars
  • Biomarkers
  • Paediatrics

Global drug development is also a key focus of the 21st Annual EuroMeeting. This year's event will include sessions on issues affecting key regions of the world, including China, Japan, Latin America, Africa, and North America. In addition, speakers from the EMEA, FDA and regulatory agencies throughout Europe will present at the event.

"The theme approach was very well received in Barcelona and will be retained in Berlin. Certain refinements around the theme sessions have been identified that will support the quest to have all disciplines interacting at our event," says Programme Co-chair Susanne Keitel, Director, European Directorate of the Quality of Medicines and Healthcare (EDQM), EU. "The 2009 programme committee has developed a meeting that truly represents the interests of all attendees."

This year's plenary session, "Architecture of the Future Governance System," will feature panelists who will set forth their vision for the next five years. Topics will include the evolution of the European Regulatory Network and the contribution of the National Competent Authorities, changes in pharmacovigilance legislation, market access and what Member States will pay for new products, and the impact of counterfeit medicines. Panelists will include:

  • Christina R. Åkerman, Director General, Medical Products Agency, Sweden
  • Daan J. A. Crommelin, Scientific Director, Top Institute Pharma - TI Pharma, Netherlands
  • Alastair Kent, Director, Genetic Interest Group, and President EGAN, UK and EU
  • Thomas Lönngren, Executive Director, EMEA, EU
  • Martin Terberger, Head of Unit, European Commission, Enterprise and Industry DG Pharmaceutical Unit, EU
  • Lisette Tiddens-Engwirda, Secretary General, Standing Committee of European Doctors, EU
  • Floortje van Nooten, Senior Research Associate - Health Economics, Health Care Analytics Group, United BioSource Corporation, Belgium

The German Satellite Session, "The Marketing Authorisation and Supervision of Medicinal Products and Patients, Doctors and Industry Expectations," will discuss the tasks, duties and cooperation of the regulatory agencies in Germany, the Federal Institute for Drugs and Medical Devices and the Paul-Ehrlich-Institut, in a changing scientific environment. This session will be co-chaired by Birka Lehmann, Director and Professor, Head of Licencing Division 3, BfArMm and Christian Schneider, Acting Head, Division EU Cooperation/Microbiology and Acting Head, Section EU Cooperation Biomedicinal Products, Paul-Ehrlich-Institut. Other presenters will include:

  • Harald Enzmann, Director and Professor, Head of Licencing Division 2, BfArM
  • Klaus Cichutek, Vice- President and Professor, Department of Medical, Biotechnology,Paul-Ehrlich-Institut
  • Karl Broich: Director and Professor, Head of Licencing Division 4, BfArM
  • Dirk Mentzer, Head, Department of Pharmacoviglance 1, Paul-Ehrlich-Institut
  • Klaus Cichutek, Vice- President and Professor, Head, Department of Medical Biotechnology, Paul-Ehrlich-Institut
  • Brigitte Keller-Stanislawski, Director and Professor, Head of Department, Safety of Medicinal Products and Medicinal Devices, Paul-Ehrlich-Institut
  • Ulrich Hagemann, Director and Professor, Head of Department Safety of Medicinal Products and Medicinal Devices, BfArM

About the Drug Information Association (DIA)
DIA serves more than 30,000 professionals in the biotechnology, pharmaceutical and regulatory industries worldwide. Through its domestic and international meetings, training courses, workshops and webinars, DIA provides a neutral global forum for the exchange of information critical to the advancement of the drug discovery and lifecycle management processes. Headquartered in Horsham, PA (USA), and with offices in Basel, Switzerland, Tokyo, Japan, Mumbai, India, and Beijing, China, the Association is led by its volunteer-based Board of Directors and executive management team. For more information, visit www.diahome.org or call 215-442-6100.

###

Read the full story at http://www.prweb.com/releases/2009/02/prweb2096544.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. The era of global aging: GSAs annual meeting to present new research on hot topics in aging
2. Perrigo Company Announces FDA Approval for Ciclopirox Topical Solution
3. Perrigo Company Announces FDA Approval for Ciclopirox Topical Solution
4. The era of global aging: GSA showcases cutting-edge San Francisco meeting topics
5. AHRQ Expands Therapeutics Education and Research Centers and Adds New Topics: Health IT, Economics, Formularies
6. Voltaren(R) Gel Receives US Regulatory Approval as the First Approved Topical Prescription Treatment for Pain Associated with Osteoarthritis
7. Warner Chilcott and NexMed Sign U.S. Collaboration for Topical Alprostadil Treatment for Erectile Dysfunction
8. JRRD releases single-topic issue on traumatic brain injury and polytrauma
9. Topical treatment for age spots, from Harvard Womens Health Watch
10. New Cleaning Industry Topics Page Provides Important Safety and Health Resources
11. Parents Identify Health Topics They Want Doctors to Discuss with Kids - New Research for University of Michigan Conducted by Knowledge Networks
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Hot Topic Sessions to Highlight DIA's 21st Annual Euromeeting 
(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... ... 001 and its sugar-free alternative VW+ 002. The drinks have been produced in ... optimal conditions to perform during your workout. , After a successful launch in ...
(Date:1/20/2017)... ... , ... “The Angel”: a heartwarming and earnest tale of faith and ... children. “The Angel” is the creation of published author, Marjorie Lund-Fontaine, a former professional ... writer. , When asked of her new book, Marjorie says, “‘The Angel’ was written ...
(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... “I Forgive You”: a fine examination ... “I Forgive You” is the creation of published author, Stephen Miller, who, for over ten ... has gracefully given to him. Born in Trinidad and Tobago, he has been serving the ...
(Date:1/20/2017)... ... January 20, 2017 , ... “Christmas in Suffolk”: ... published author, Sara Seymour, who lives in Lafayette, Indiana where she works in a ... iced coffees and writes. , Published by Christian Faith Publishing, Sara Seymour’s new book ...
(Date:1/20/2017)... ... ... is God’s Lighthouse”: a moving and colorful collection of prayers that reminds readers ... author, Gene Gaapf, a retired truck driver, and a long-time writer, whose published works ... school and have many different titles,” Gaapf mentions about his different works. “I am ...
Breaking Medicine News(10 mins):
(Date:1/21/2017)... , Jan. 20, 2017  Faruqi & Faruqi, LLP, a ... ("KemPharm" or the "Company") (NASDAQ: KMPH ) of ... and certain officers and directors and underwriters of the Company,s ... the role of lead plaintiff. The lawsuit has ... Court for Johnson County on behalf ...
(Date:1/20/2017)... Research and Markets has announced the ... Implant Types, OTC Amplifiers, Diagnostic Instruments), Sales Volume, Company Analysis ... ... Aids Market Sales Volume, Company Analysis and Forecast to 2022 ... industry. The growing prevalence of hearing impairment coupled ...
(Date:1/20/2017)... Stock-Callers.com today evaluates the following Drug Manufacturers equities: ... A/S (NYSE: NVO ), Sucampo Pharmaceuticals Inc. (NASDAQ: ... PTX ). These stocks belong to the Healthcare ... finishing near its session lows. As per a NASDAQ report, ... of health care companies in the S&P 500 also were ...
Breaking Medicine Technology: